Intestinal Research

IBD
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment: Shintaro Akiyama, Victoria Rai, David T. Rubin; Intest Res. 2021;19(1):1-11. Published online November 5, 2020; DOI: https://doi.org/10.5217/ir.2020.00047
Cited By 15; Full text PubReader ePub Crossref - TDM PDF

Cancer
Two intertwined compartments coexisting in sporadic conventional colon adenomas: Carlos A. Rubio; Intest Res. 2021;19(1):12-20. Published online February 24, 2020; DOI: https://doi.org/10.5217/ir.2019.00133
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

IBD
Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases: Julajak Limsrivilai, Nonthalee Pausawasdi; Intest Res. 2021;19(1):21-32. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09142
Cited By 24; Full text PubReader ePub Crossref - TDM PDF

Endoscopic molecular imaging in inflammatory bowel disease: Nam Seok Ham, Seung-Jae Myung; Intest Res. 2021;19(1):33-44. Published online April 20, 2020; DOI: https://doi.org/10.5217/ir.2019.09175
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

Inflammatory Bowel Diseases
Quality of life in inflammatory bowel diseases: it is not all about the bowel: Ronald Keller, Nazar Mazurak, Laura Fantasia, Stefano Fusco, Nisar P Malek, Jan Wehkamp, Paul Enck, Thomas Klag; Intest Res. 2021;19(1):45-52. Published online February 27, 2020; DOI: https://doi.org/10.5217/ir.2019.00135
Cited By 16; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis: Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel; Intest Res. 2021;19(1):53-61. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09146
Cited By 14; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis: Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park; Intest Res. 2021;19(1):62-70. Published online May 8, 2020; DOI: https://doi.org/10.5217/ir.2019.09156
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study: Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul; Intest Res. 2021;19(1):71-82. Published online September 4, 2020; DOI: https://doi.org/10.5217/ir.2019.09159
Cited By 16; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study: Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, Deng-Chyang Wu, Suk-Kyun Yang, Dirk Demuth, Dirk Lindner, Shashi Adsul; Intest Res. 2021;19(1):83-94. Published online December 31, 2020; DOI: https://doi.org/10.5217/ir.2019.09160
Cited By 13; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease: Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, Toshifumi Hibi; Intest Res. 2021;19(1):95-105. Published online July 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09167
Cited By 11; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Miscellaneous
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver: Ashish Agarwal, Alka Singh, Wajiha Mehtab, Vipin Gupta, Ashish Chauhan, Mahendra Singh Rajput, Namrata Singh, Vineet Ahuja, Govind K. Makharia; Intest Res. 2021;19(1):106-114. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.00136
Cited By 19; Full text PubReader ePub Crossref - TDM PDF

IBD
Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis: Hiromichi Shimizu, Toshimitsu Fujii, Shuji Hibiya, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe; Intest Res. 2021;19(1):115-118. Published online June 11, 2020; DOI: https://doi.org/10.5217/ir.2020.00030
Cited By 9; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Infection
Whipple disease mimicking inflammatory bowel disease: Maiko Tatsuki, Takashi Ishige, Yoshiko Igarashi, Reiko Hatori, Akira Hokama, Junko Hirato, Aleixo Muise, Takumi Takizawa, Hirokazu Arakawa; Intest Res. 2021;19(1):119-125. Published online July 3, 2020; DOI: https://doi.org/10.5217/ir.2019.09177
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

Previous issues